SU611598A3 - Method of counting leucocytes - Google Patents

Method of counting leucocytes

Info

Publication number
SU611598A3
SU611598A3 SU711711809A SU1711809A SU611598A3 SU 611598 A3 SU611598 A3 SU 611598A3 SU 711711809 A SU711711809 A SU 711711809A SU 1711809 A SU1711809 A SU 1711809A SU 611598 A3 SU611598 A3 SU 611598A3
Authority
SU
USSR - Soviet Union
Prior art keywords
solution
cells
staining
reagent
hemolysis
Prior art date
Application number
SU711711809A
Other languages
Russian (ru)
Inventor
Р. Анслей Гудсон
Орнстейн Леонард
Original Assignee
Моунт Синай Рисерч Фаундэйшн (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Моунт Синай Рисерч Фаундэйшн (Фирма) filed Critical Моунт Синай Рисерч Фаундэйшн (Фирма)
Application granted granted Critical
Publication of SU611598A3 publication Critical patent/SU611598A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N2001/305Fixative compositions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/808Optical sensing apparatus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/11Automated chemical analysis
    • Y10T436/117497Automated chemical analysis with a continuously flowing sample or carrier stream
    • Y10T436/118339Automated chemical analysis with a continuously flowing sample or carrier stream with formation of a segmented stream

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Description

1one

Изобретение относитс  к области медицины и может быть использовано в диагностической практике дл  определени  содержани  лейкоцитов в крови.The invention relates to the field of medicine and can be used in diagnostic practice for determining the content of leukocytes in the blood.

Известен способ подсчета лейкоцитов путем фиксации, ферментативного окрашивани  и гемолиза 1 .There is a method for counting leukocytes by fixation, enzymatic staining and hemolysis 1.

Однако известный способ не обеспечивает дифференциального подсчета лейко1штов от других форменных элементов крови.However, the known method does not provide differential counting of leucomas from other blood corpuscles.

Целью изобретени   вл етс  дифференциальный подсчет лейкоцитов от других форменных злементов крови, например, с помощью фотометрии .The aim of the invention is the differential count of leukocytes from other blood cells, for example, by means of photometry.

Эта цель достигаетс  тем, что фиксацию цельной крови провод т моноальдегидом с последующим гемолизом и окрашиванием цитохимическим субстратом, смешанным с хромогенным сопр гающим реагентом, который не образует внеклеточных макрочастиц, добавлением буферной смеси дл  регулировани  рН и подогревом полученной смеси от 20 до 55°С в течение 1-10 мин.This goal is achieved by fixing whole blood with monoaldehyde followed by hemolysis and staining with a cytochemical substrate mixed with a chromogenic conjugating reagent that does not form extracellular particulates, adding a buffer mixture to adjust the pH and heating the resulting mixture from 20 to 55 ° C. for 1-10 min.

Кроме того, при окраишвании нейтрофилов и ЭОЗИНОФИ.ИОВ, в качестве цитохимического окрашивающего субстрата используют перекись, а хромогенного сопр гающего реагента - 4-хлор-1-нафтал , а дл  окрашивани  моноцитов в качестве цитохимического окрашивающего субстрата используют альфа-нафтилбутират, а хромогенного сопр гающего р .агента - гексазоний - парарозанилин.In addition, when staining neutrophils and EOSINOFI.IOV, peroxide is used as a cytochemical staining substrate, 4-chloro-1-naphthal is used as a chromogenic conjugate reagent, and alpha naphthyl butyrate is used as a cytochemical staining substrate, and chromogenic conjugate is used. Hexazonium - pararosaniline.

Способ осуществл ют следующим образом.The method is carried out as follows.

Добавл ют отологический фиксирующий реактив к раствору, содержащему белые кров ные клетки (например, цельную кровь) дл  умерщвлени  содержащихс  там кров ных клеток и иммобилизации содержащихс  з клетках каталитических знзимов. Предпочтительными  вл ютс  пробы жидкости организма, такие, как цельна  кровь и спинномозгова  жидкость. После добавки фиксирующего реактива раствор обрабатьшают особым цитохимическим веществом, хромогенными осаждающим копулирующим реактивом и буфером.An otologic fixative reagent is added to a solution containing white blood cells (for example, whole blood) to kill the contained blood cells and immobilize the contained catalytic cells. Preferred are body fluid samples, such as whole blood and cerebrospinal fluid. After the addition of fixing reagent, the solution is treated with a special cytochemical substance, chromogenic precipitating copulating reagent and buffer.

Цитологический фиксирующий раствор) представл ет собой преимущественно 0,2-40%-ный водный раствор моноальдегида, такого как формальдегид , бутиральдегид, пропиональдегид и ацетальдегид . Диальдегиды непригодны, так как обуслоливают сетчатую структуру и вызывают внеклеточ ные осаждени .The cytological fixative solution is a predominantly 0.2-40% aqueous solution of monoaldehyde, such as formaldehyde, butyraldehyde, propionaldehyde, and acetaldehyde. Dialdehydes are unsuitable because they cause the mesh structure and cause extracellular precipitation.

Концентраци  моноальдегида Должна быть достаточно высока дл  умерщвлени  клеток, однако , без нарушени  активности энзим.The concentration of monoaldehyde should be high enough to kill the cells, however, without disrupting the activity of the enzyme.

Низкие концентрации при 1шзких температурах требуют дополнительного времени. Так, например , при концентрации формальдегида в растворе равной 2%, при 4°С требуетс  12 ч, а при 4%-ной концентрации при 50°С требуетс  2 мин.Low concentrations at low temperatures require additional time. For example, at a concentration of formaldehyde in a solution of 2%, at 4 ° C it takes 12 hours, and at 4% concentration at 50 ° C it takes 2 minutes.

Так как обычно смецювают равные объемы жидкости организма и раствора моноальдегида, крепость альдегадного раствора  вл етс  двойной по сравнению с концентрацией во врем  фиксашш альдегида в растворе.Since equal volumes of body fluid and monoaldehyde solution are usually mixed, the strength of the aldehyde solution is double compared to the concentration during fixation of the aldehyde in solution.

Предпочтительным  вл етс  37%-ный раствор формальдегида.A 37% formaldehyde solution is preferred.

Когда жидкость организма, содержаида  лейкоциты , представл ет собой цельную кровь, то необходимо осуществить гемолиз лейкоцитов, так как существует опасность, что совпадающее прохождение двух или большего количества красных клеток через фотометрическую счетную стандаю ошибочно может быть прин то как окрашенные лейкоциты или ненормальные клетки. Дл  этого осуиюствл ют гемолиз красных кров ных клеток путем добавлени  реагента к суспензии клеток, чтобы обусловить разрьш только красных клеток и вьоделение их содержимого (например, гемоглобина ) в .раствор. When the body fluid containing leukocytes is whole blood, hemolysis of leukocytes is necessary, since there is a danger that the coinciding passage of two or more red cells through a photometric counting can be mistakenly taken as painted leukocytes or abnormal cells. For this purpose, hemolysis of red blood cells is carried out by adding the reagent to the cell suspension in order to cause the red cells to be discharged and their contents (for example, hemoglobin) to be discharged into the solution.

Гемолиризующие реагенты не должны сверть1вать взвешенные клетки и не должны мешать протеканию Л1юбых последующих гистохимических реакций путем, например, взаимодействи  с какими-либо соединени ми; используемыми дл  окрашивани  клеток на послещшх этапах.Hemolyzing reagents should not curtail suspended cells and should not interfere with the flow of any subsequent histochemical reactions by, for example, interacting with any compounds; used for staining cells in the post stages.

Гемолиз провод т либо до, либо после окрашивани . Если гемолиз провод т после окрашивани , то это не должно сушественио измен ть окраску или измен ть окрашенные или неокрашенны лейкоциты.Hemolysis is carried out either before or after staining. If hemolysis is carried out after staining, this should not change color or change stained or unstained white blood cells.

Гемолиз провод т введением в раствор, содержащий красные и белые кров ные клетки, водного раствора алифатической кислоты с величиной рН |3,0-5,5. Удовлетворительные результаты дает применение уксусной, пропионовой, масл ной и молочной кислот в концентрации 1-10%.Hemolysis is carried out by introducing into a solution containing red and white blood cells an aqueous solution of aliphatic acid with a pH value of | 3.0-5.5. Satisfactory results are obtained by using acetic, propionic, butyric, and lactic acids in a concentration of 1–10%.

Предпочтительным  вл етс  раствор уксусной кислоты концентрации около 7%. Раствор может быть нагрет до температур, начина  от 40 (в течение 8 мин) до 55°С (в течение 1 мин), чем достигаетс  инактиваци  энзима катализы, снижение псевдопероксидазной активности гемоглобина и ускорение гемолиза. При более низких температурах дл  реак1ии требуетс  больше времени. Использование еще более высоких температур инактивирует энзимы пероксидазы и ускор ет свертывание после введени  гемолизирующего реагента.Acetic acid solution of about 7% is preferred. The solution can be heated to temperatures ranging from 40 (within 8 minutes) to 55 ° C (within 1 minute), which results in inactivation of the catalysis enzyme, reduction of the hemoglobin pseudoperoxidase activity and acceleration of hemolysis. At lower temperatures, reaction takes longer. The use of even higher temperatures inactivates peroxidase enzymes and accelerates clotting after the introduction of the hemolyzing agent.

Окрашивание клеток требует тщательного выбора реактивов. Используют большое ко;шчествоCell staining requires careful selection of reagents. They use a lot of quality

известных цитохимических субстратов. Так дл  окрашивани  клеток, содержащих пероксидазу, таких как эозинофилы или нейтрофилы, примен ют смес§ неорганической или органической перекиси и 4-хпоро-1-нафтала . Перекись и 4-хлоро.1-нафтал служат в качестве энзимных субстратов, а 4-хлоро-1нафтал служит также в качестве копулирующего реагента. 4-Хлрро-1-нафтал производит темно-синее окрашивание внутри содержащей пероксидазу клетки без введени  отдельного хромогенного осаждающего копулирующего реактива. Можно также использовать смесь (7-толидина и 4-хлоро-Ьнафтала дл  получени  пурпурно-красного красител , если используемый на ступени фиксировани  формальресид инактивирован.known cytochemical substrates. Thus, a mixture of inorganic or organic peroxide and 4-hporo-1-naphthal is used to stain cells containing peroxidase, such as eosinophils or neutrophils. Peroxide and 4-chloro.1-naphthal serve as enzyme substrates, and 4-chloro-1 naphthal also serves as a copulating reagent. 4-Chlrro-1-naphthal produces a dark blue stain inside the peroxidase-containing cell without the introduction of a separate chromogenic precipitating copulating reagent. It is also possible to use a mixture of (7-tolidine and 4-chloro-baphthal to produce a purple-red dye if the formalreside used in the fixation step is inactivated.

Дл  избирательного окрашивани  контролируют рН раствора. Если рН раствора ниже 3,0, то т желые осадки красител  образуютс  только в зозинофилах. Если рН раствора находитс  в пределах 3,0-5,0, то т желые осадки красител  образуютс  только в нейтрофилах. Если рН находитс  в пределах 5,0-7,0, то т желые осадки красител  образуютс  только в эозинофилах и нейтрофилах.The pH of the solution is monitored for selective staining. If the pH of the solution is below 3.0, then heavy precipitates of the dye are formed only in the rosinophils. If the pH of the solution is in the range of 3.0-5.0, then heavy precipitates of the dye are formed only in neutrophils. If the pH is in the range of 5.0-7.0, then heavy precipitates of the dye are formed only in eosinophils and neutrophils.

ЕСЛИ окрашивают липазосодержащие клетки,IF stained with lipase-containing cells,

т.е. моноциты, то используют комбинации сложного эфира, нафтола, такого как 1-нафтилацетата или 1-нафтилбутирата и диамониевой соли, например , гексазоний - парарозанилии, который  вл етс  хромогенным осаждающим копулирующим реагентом; рН дл  этой реакции окрашивани  5,56 ,5, предпочтительно около 6,0, при такой рН т желые осадки красителей образуютс  только в моноцитах .those. monocytes, then combinations of an ester, naphthol, such as 1-naphthylacetate or 1-naphthylbutyrate and a diamonium salt, such as hexazonium — pararosanilium, which is a chromogenic precipitating copulating reagent; The pH for this dyeing reaction is 5.56, 5, preferably about 6.0, at this pH, heavy precipitates of dyes are formed only in monocytes.

С целью адекватного цветного окрацшвани For the purpose of adequate color painting

в моноцитах за короткий отрезок времени, например за 5 мин концентраци  субстрата должна превышать примерно 0,5 мг/мл в окончательном инкуба1шонном растворе. Сложные зфиры нафтал-AS и их производные и 1-нафтилбутират менее растворимы, чем 0,5 мг/мл, поэтому в них ввод т 2,2-оксидиэтанол (диэтиленгликоль) или другие водные спирты или эфиры, например этиленгликоль, пропиленгликоль, диметиловый эфир этиленгликол in monocytes in a short period of time, for example, in 5 minutes, the concentration of the substrate should exceed about 0.5 mg / ml in the final incubation solution. Naphthal-AS esters and their derivatives and 1-naphthylbutyrate are less soluble than 0.5 mg / ml, therefore 2,2-oxydiethanol (diethylene glycol) or other aqueous alcohols or ethers, for example ethylene glycol, propylene glycol, dimethyl ether, are introduced into them. ethylene glycol

к диэтилкарбитол .to diethylcarbitol.

После этого 1-нафтилбутират и 1-нафтилацетат могут быть растворены в концентраци х до 1 мг/мл. Могут быть растворены также и другиеThereafter, 1-naphthylbutyrate and 1-naphthyl acetate can be dissolved at concentrations up to 1 mg / ml. Others may also be dissolved.

субстраты, такие как нафтилхлорацетат, сложные индоксильные эфиры, такие как сложные эфиры индоксилацетата, индоксилпропионата и индоксилбутирата , сложные эфиры 8-оксихино;тина, такие как 8-оксихинолинацетат, 7-оксихииолиниропиоиатsubstrates, such as naphthyl chloroacetate, indoxyl esters, such as esters of indoxyl acetate, indoxyl propionate and indoxyl butyrate, esters of 8-hydroxychino; tina, such as 8-hydroxyquinoline, 7-hydroxyiiioliniropioate

и 8-оксихинолинбутарат. При тех же услови х будет растворено только около 0,1 мг/мл нафтал-AS-ацетата , что приводит к значительно более слабому вы влению цветного окрашива1ш . Другие сложные зфиры производных иафтал-AS раствор ютс  даже в меньшей степени.and 8-hydroxyquinoline butarate. Under the same conditions, only about 0.1 mg / ml of naphthal-AS-acetate will be dissolved, which leads to a significantly weaker color staining. Other ester derivatives of the afatal-AS are even less soluble.

SU711711809A 1970-10-30 1971-10-29 Method of counting leucocytes SU611598A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8533370A 1970-10-30 1970-10-30

Publications (1)

Publication Number Publication Date
SU611598A3 true SU611598A3 (en) 1978-06-15

Family

ID=22190904

Family Applications (1)

Application Number Title Priority Date Filing Date
SU711711809A SU611598A3 (en) 1970-10-30 1971-10-29 Method of counting leucocytes

Country Status (12)

Country Link
US (1) US3741875A (en)
JP (2) JPS576932B1 (en)
AU (1) AU460469B2 (en)
BE (1) BE774311A (en)
CA (1) CA960947A (en)
DE (1) DE2153479B2 (en)
FR (1) FR2113336A5 (en)
GB (1) GB1331568A (en)
IT (1) IT961518B (en)
NL (1) NL172463C (en)
SE (1) SE372417B (en)
SU (1) SU611598A3 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125699B2 (en) * 1971-05-25 1973-05-17 Phywe AG, 3400 Gottingen PREPARATION OF CELLS FOR THE MEASUREMENT OF DNA
US4049381A (en) * 1976-03-23 1977-09-20 Technicon Instruments Corporation Apparatus and method of fluid sample analysis
US4099917A (en) * 1977-07-21 1978-07-11 Technicon Instruments Corporation Process for preparing a cell suspension from blood for discrimination of white blood cells and platelets from other blood particles
DE2826965A1 (en) * 1978-06-20 1980-01-17 Boehringer Mannheim Gmbh DIAGNOSTIC AGENT FOR DETECTING LEUCOCYTES IN BODY LIQUIDS AND CHROMOGENES SUITABLE FOR THIS
US4581223A (en) * 1980-03-12 1986-04-08 Lawrence Kass Individual leukocyte determination by means of differential metachromatic dye sorption
US4492752A (en) * 1982-09-03 1985-01-08 Ortho Diagnostics Systems Inc. Method for discriminating between unstained and absorbing dye stained cells
CA1254134A (en) * 1984-03-28 1989-05-16 Mount Sinai School Of Medicine Of The City University Of New York Specific binding flow cytometry method
US4654312A (en) * 1984-05-14 1987-03-31 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
US4751179A (en) * 1984-05-31 1988-06-14 Coulter Electronics, Inc. Method and reagents for differential determination of four populations of leukocytes in blood
US4801549A (en) * 1985-09-06 1989-01-31 Technicon Instruments Corporation Method for the determination of a differential white blood cell count
US4978624A (en) * 1985-09-06 1990-12-18 Technicon Instruments Corporation Reagent for the determination of a differential white blood cell count
AU602129B2 (en) * 1985-09-06 1990-10-04 Technicon Instruments Corportion Method for the determination of a differential white blood cell count
US5389549A (en) * 1987-05-29 1995-02-14 Toa Medical Electronics Co., Ltd. Method for classifying leukocytes and a reagent used therefor
AU3182289A (en) * 1988-02-10 1989-09-22 Nygene Corporation Process for producing biochemicals
US5316725A (en) * 1991-06-07 1994-05-31 Edward Lawrence Carver, Jr. Reagent system for the improved determination of white blood cell subpopulations
US5262329A (en) * 1991-06-13 1993-11-16 Carver Jr Edward L Method for improved multiple species blood analysis
US6046019A (en) * 1991-07-09 2000-04-04 Goumeniouk; Alexander P. Diagnostic kits and methods for making granulocyte cell counts
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
US6362003B1 (en) 1992-02-24 2002-03-26 Coulter Corporation Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
ATE193603T1 (en) * 1992-02-24 2000-06-15 Coulter Corp SUSPENSION MEDIA FOR HEMATOLIGIC COMPOSITIONS AND METHOD FOR THEIR USE
AU665413B2 (en) * 1992-02-24 1996-01-04 Coulter International Corporation Hematology control composition for leukocyte analogs; and methods for their preparation and use
US6812032B1 (en) * 1993-01-21 2004-11-02 Cdc Technologies, Inc. Apparatus and method for making a plurality of reagent mixtures and analyzing particle distributions of the reagent mixtures
US5599501A (en) * 1994-11-10 1997-02-04 Ciba Corning Diagnostics Corp. Incubation chamber
WO1996034283A1 (en) * 1995-04-27 1996-10-31 Hematronix, Inc. Lytic system utilizing propionic acid for leukocytes differentiation
US5639630A (en) * 1995-05-16 1997-06-17 Bayer Corporation Method and reagent composition for performing leukocyte differential counts on fresh and aged whole blood samples, based on intrinsic peroxidase activity of leukocytes
US5686308A (en) * 1995-06-08 1997-11-11 Coulter Corporation Reagent and method for differential determination of leukocytes in blood
US5843608A (en) * 1995-06-08 1998-12-01 Coulter International Corp. Reagent and method for differential determination of leukocytes in blood
US6146901A (en) * 1997-06-16 2000-11-14 Hematronix, Inc. Composition for manipulating optical and electrical properties of particles to achieve target values for such properties and methods for using the composition
US6759246B1 (en) 2001-11-30 2004-07-06 Research & Diagnostic Systems, Inc. Hematology control composition including lymphocyte analogs and method for preparation and use
CA2428740A1 (en) 2002-05-20 2003-11-20 Bayer Corporation Automated method and reagent therefor for assaying body fluid samples such as cerebrospinal fluid (csf)
EP2525222A1 (en) 2011-05-17 2012-11-21 Markus M. Heiss Initial relative lymphocyte count as predictive biomarker
US11072843B2 (en) 2016-09-27 2021-07-27 Novelis Inc. Systems and methods for non-contact tensioning of a metal strip

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2807416A (en) * 1953-07-13 1957-09-24 Ohio Commw Eng Co Device for automatically counting blood cells
DE1200577B (en) * 1962-05-29 1965-09-09 Habil Hans Meyer Doering Dr Me Arrangement for counting the particles carried in a flow-capable and translucent medium that influence the brightness of a light beam directed at them
US3413464A (en) * 1965-04-29 1968-11-26 Ibm Method for measuring the nucleic acid in biological cells after enhancement in an acidic solution
US3523733A (en) * 1966-01-05 1970-08-11 Technicon Corp Method and apparatus for particle counting
US3427135A (en) * 1966-07-11 1969-02-11 Technicon Instr Hematology apparatus

Also Published As

Publication number Publication date
GB1331568A (en) 1973-09-26
AU3484771A (en) 1973-05-03
BE774311A (en) 1972-04-24
FR2113336A5 (en) 1972-06-23
US3741875A (en) 1973-06-26
DE2153479B2 (en) 1975-06-05
SE372417B (en) 1974-12-23
DE2153479A1 (en) 1972-05-04
CA960947A (en) 1975-01-14
JPS56163455A (en) 1981-12-16
NL172463C (en) 1983-09-01
AU460469B2 (en) 1975-04-24
NL7114995A (en) 1972-05-03
JPS576932B1 (en) 1982-02-08
IT961518B (en) 1973-12-10

Similar Documents

Publication Publication Date Title
SU611598A3 (en) Method of counting leucocytes
DE2153479C3 (en)
Vermylen et al. A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)
Tracey Chitinase in some Basidiomycetes
ES2367979T3 (en) PROCEDURE FOR DETECTING AND LISTING MICROORGANISMS QUICKLY IN PREPARATIONS OF CELLS OF MAMMALS USING THE BIOLUMINISCENCE OF ATP.
US3630847A (en) Diagnostic agent for use in the determination of hydroperoxides and of peroxidate-active substances
Oliver et al. [33] Use of horseradish peroxidase and fluorescent dextrans to study fluid pinocytosis in leukocytes
Gallyas et al. Copper-H2O2 oxidation strikingly improves silver intensification of the nickel-diaminobenzidine (Ni-DAB) end-product of the peroxidase reaction.
JPS60259185A (en) Method for obtaining glycerine oxidase
US4493892A (en) Solvent system for peroxidase inhibitor reagent for fecal occult blood determinations
Blum et al. Oxidation of serotonin and 5-hydroxyindoles during the denaturation of oxyhaemoglobin
Edson The oxidation of lactic acid by Mycobacterium phlei
Schothorst et al. Metabolic aspects of the photodynamic effect of protoporphyrin in protoporphyria and in normal red blood cells
Goff A light and electron microscopic study of peroxidase localization in the onion root tip
Van Noorden et al. A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes: I. Optimalization of the staining procedure
O'brien Identification of haemoglobin by its catalase reaction with peroxide and o-dianisidine
Gordon et al. Estimation of lactic acid in biological material by oxidation with ceric sulphate
Jung et al. An improved reagent system for the measurement of serum uric acid
US2990338A (en) Composition for determination of glucose in body fluids
US3616259A (en) Screening procedure for enzyme deficiencies
Gowenlock The estimation of tryptic activity in duodenal contents
US3362886A (en) Composition and method for the detection of galactose
US4030885A (en) Bilirubin determination
Ribarov et al. A chemiluminescent method for measurement of activated oxygen forms in biological fluids and homogenates
Begemann et al. Staining methods